Significance of nm23 Immunoexpression in the Prognosis of Renal Cell Carcinoma

被引:2
作者
Filiz, G. [1 ]
Adim, S. [1 ]
Aytac, B. [1 ]
Akar, E. [1 ]
Vuruskan, H. [2 ]
机构
[1] Uludag Univ, Sch Med, Dept Surg Pathol, TR-16059 Bursa, Turkey
[2] Uludag Univ, Sch Med, Dept Urol, TR-16059 Bursa, Turkey
关键词
RENAL CELL CARCINOMA; NM23; IMMUNOHISTOCHEMISTRY; PROGNOSIS; EXPRESSION; PROTEIN; METASTASIS; ASSOCIATION; CANCER; STAGE;
D O I
10.1177/147323001003800224
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-metastatic gene 23 (nm23) is a metastasis suppressor gene that is expressed in all tissues and decreased nm23 expression may be linked to poor prognosis. By immunohistochemical staining of nm23 protein antibodies this study examined the prognostic value of nm23 protein expression in 54 renal cell carcinoma (RCC) patients and analysed its relationship with tumour, node, metastases (TNM) surgical stage, Fuhrman nuclear grade, lymph node involvement and survival. Of the 54 RCC cases studied, 11 (20.4%) showed positive lymph node involvement while 43 (79.6%) were lymph node negative. There was no difference in nm23 protein expression between cases with and without lymph node involvement. In addition, nm23 protein expression was not related to TNM stage, Fuhrman nuclear grade or survival. More extensive studies are required to understand the effect of nm23 protein expression on the biological behaviour of RCC.
引用
收藏
页码:620 / 624
页数:5
相关论文
共 21 条
[1]   REDUCED EXPRESSION OF NM23 PROTEIN IS ASSOCIATED WITH ADVANCED TUMOR STAGE AND DISTANT METASTASES IN HUMAN COLORECTAL CARCINOMAS [J].
AYHAN, A ;
YASUI, W ;
YOKOZAKI, H ;
KITADAI, Y ;
TAHARA, E .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1993, 63 (04) :213-218
[2]  
BACKER JM, 1993, ONCOGENE, V8, P497
[3]  
BARNES R, 1991, AM J PATHOL, V139, P245
[4]   Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0):: The impact of aggressive surgical resection on patient outcome [J].
Canfield, SE ;
Kamat, AM ;
Sánchez-Ortiz, RF ;
Detry, M ;
Swanson, DA ;
Wood, CG .
JOURNAL OF UROLOGY, 2006, 175 (03) :864-869
[5]   Sorafenib in advanced clear-cell renal-cell carcinoma [J].
Escudier, Bernard ;
Eisen, Tim ;
Stadler, Walter M. ;
Szczylik, Cezary ;
Oudard, Stephane ;
Siebels, Michael ;
Negrier, Sylvie ;
Chevreau, Christine ;
Solska, Ewa ;
Desai, Apurva A. ;
Rolland, Frederic ;
Demkow, Tomasz ;
Hutson, Thomas E. ;
Gore, Martin ;
Freeman, Scott ;
Schwartz, Brian ;
Shan, Minghua ;
Simantov, Ronit ;
Bukowski, Ronald M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :125-134
[6]  
FLORENES VA, 1992, CANCER RES, V52, P6088
[7]   PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663
[8]   Proliferative activity, angiogenesis and nuclear morphometry in renal cell carcinoma [J].
Kirkali, Z ;
Yorukoglu, K ;
Ozkara, E ;
Kazimoglu, H ;
Mungan, U .
INTERNATIONAL JOURNAL OF UROLOGY, 2001, 8 (12) :697-703
[9]   Prognostic biomarkers of renal cell carcinoma: Recent advances [J].
Kitamura, Hiroshi ;
Tsukamoto, Taiji .
INDIAN JOURNAL OF UROLOGY, 2008, 24 (01) :10-15
[10]  
Kuo JY, 1998, ANTICANCER RES, V18, P531